The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Effect of Laparoscopic-Assisted Resection vs Open Resection on Pathological Outcomes in Rectal Cancer: The ALaCaRT Randomized Clinical Trial
Open accessAbstract
IMPORTANCE: Laparoscopic procedures are generally thought to have better outcomes than open procedures. Because of anatomical constraints, laparoscopic rectal resection may not be better because of limitations in performing an adequate cancer resection. OBJECTIVE: To determine whether laparoscopic resection is noninferior to open rectal cancer resection for adequacy of cancer clearance. DESIGN, SETTING, AND PARTICIPANTS: Randomized, noninferiority, phase 3 trial (Australasian Laparoscopic Cancer of the Rectum; ALaCaRT) conducted between March 2010 and November 2014. Twenty-six accredited surgeons from 24 sites in Australia and New Zealand randomized 475 patients with T1-T3 rectal adenocarcinoma less than 15 cm from the anal verge. INTERVENTIONS: Open laparotomy and rectal resection (n = 237) or laparoscopic rectal resection (n = 238). MAIN OUTCOMES AND MEASURES: The primary end point was a composite of oncological factors indicating an adequate surgical resection, with a noninferiority boundary of Δ = -8%. Successful resection was defined as meeting all the following criteria: (1) complete total mesorectal excision, (2) a clear circumferential margin (≥1 mm), and (3) a clear distal resection margin (≥1 mm). Pathologists used standardized reporting and were blinded to the method of surgery. RESULTS: A successful resection was achieved in 194 patients (82%) in the laparoscopic surgery group and 208 patients (89%) in the open surgery group (risk difference of -7.0% [95% CI, -12.4% to ∞]; P = .38 for noninferiority). The circumferential resection margin was clear in 222 patients (93%) in the laparoscopic surgery group and in 228 patients (97%) in the open surgery group (risk difference of -3.7% [95% CI, -7.6% to 0.1%]; P = .06), the distal margin was clear in 236 patients (99%) in the laparoscopic surgery group and in 234 patients (99%) in the open surgery group (risk difference of -0.4% [95% CI, -1.8% to 1.0%]; P = .67), and total mesorectal excision was complete in 206 patients (87%) in the laparoscopic surgery group and 216 patients (92%) in the open surgery group (risk difference of -5.4% [95% CI, -10.9% to 0.2%]; P = .06). The conversion rate from laparoscopic to open surgery was 9%. CONCLUSIONS AND RELEVANCE: Among patients with T1-T3 rectal tumors, noninferiority of laparoscopic surgery compared with open surgery for successful resection was not established. Although the overall quality of surgery was high, these findings do not provide sufficient evidence for the routine use of laparoscopic surgery. Longer follow-up of recurrence and survival is currently being acquired. TRIAL REGISTRATION: anzctr.org Identifier: ACTRN12609000663257.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer
Kapiteijn, E., Marijnen, C. A. M., Nagtegaal, I. D., Putter, H., Steup, W. H., Wiggers, T., Rutten, H. J. T., Pahlman, L., Glimelius, B., van Krieken, J. H. J. M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010580 · Cited by 4,205 · cited 7×
“Time requiring parenteral narcotics 2 (1-3)b 2 (1-3)c .”
InfluentialGuillou, P. J., Quirke, P., Thorpe, H., Walker, J., Jayne, D. G., Smith, A. M., Heath, R. M., & Brown, J. M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66545-2 · Cited by 3,064
RECURRENCE AND SURVIVAL AFTER TOTAL MESORECTAL EXCISION FOR RECTAL CANCER
Heald, R. J., & Ryall, R. D. H. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91510-2 · Cited by 2,710
Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial
(2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70221-7 · Cited by 2,316
van Gijn, W., Marijnen, C. A., Nagtegaal, I. D., Kranenbarg, E. M.-K., Putter, H., Wiggers, T., Rutten, H. J., Påhlman, L., Glimelius, B., & van de Velde, C. J. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70097-3 · Cited by 1,888
Jayne, D. G., Guillou, P. J., Thorpe, H., Quirke, P., Copeland, J., Smith, A. M. H., Heath, R. M., & Brown, J. M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.7758 · Cited by 1,497
A Randomized Trial of Laparoscopic versus Open Surgery for Rectal Cancer
Bonjer, H. J., Deijen, C. L., Abis, G. A., Cuesta, M. A., van der Pas, M. H. G. M., de Lange-de Klerk, E. S. M., Lacy, A. M., Bemelman, W. A., Andersson, J., Angenete, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414882 · Cited by 1,437
Fleshman, J., Sargent, D. J., Green, E., Anvari, M., Stryker, S. J., Beart, R. W., Hellinger, M., Flanagan, R., Peters, W., & Nelson, H. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e318155a762 · Cited by 1,124
Quirke, P., Steele, R., Monson, J., Grieve, R., Khanna, S., Couture, J., O'Callaghan, C., Myint, A. S., Bessell, E., Thompson, L. C., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60485-2 · Cited by 1,053
What Is the Role for the Circumferential Margin in the Modern Treatment of Rectal Cancer?
Nagtegaal, I. D., & Quirke, P. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.7027 · Cited by 1,006
Nagtegaal, I. D., van de Velde, C. J. H., van der Worp, E., Kapiteijn, E., Quirke, P., van Krieken, J. H. J. M., & the Pathology Review Committee for the Cooperative Clinical Investigators of the Dutch Colorectal Cancer Group (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.010 · Cited by 922
Jeong, S.-Y., Park, J. W., Nam, B. H., Kim, S., Kang, S.-B., Lim, S.-B., Choi, H. S., Kim, D.-W., Chang, H. J., Kim, D. Y., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70205-0 · Cited by 888
Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial
Kusters, M., Marijnen, C. A. M., van de Velde, C. J. H., Rutten, H. J. T., Lahaye, M. J., Kim, J. H., Beets-Tan, R. G. H., & Beets, G. L. (2010) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2009.11.011 · Cited by 344
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer
Noël, G., & Mazeron, J. J. (2002) · Cancer/Radiothérapie · doi:10.1016/s1278-3218(02)00192-0 · Cited by 338
Cited by
Gustafsson, U. O., Scott, M. J., Hubner, M., Nygren, J., Demartines, N., Francis, N., Rockall, T. A., Young‐Fadok, T. M., Hill, A. G., Soop, M., et al. (2019) · World Journal of Surgery · doi:10.1007/s00268-018-4844-y · Cited by 2,119
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer
Ramirez, P. T., Frumovitz, M., Pareja, R., Lopez, A., Vieira, M., Ribeiro, R., Buda, A., Yan, X., Shuzhong, Y., Chetty, N., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1806395 · Cited by 1,874
Self-citationJayne, D., Pigazzi, A., Marshall, H., Croft, J., Corrigan, N., Copeland, J., Quirke, P., West, N., Rautio, T., Thomassen, N., et al. (2017) · JAMA · doi:10.1001/jama.2017.7219 · Cited by 1,450
Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Benson, A. B., Venook, A. P., Al-Hawary, M. M., Cederquist, L., Chen, Y.-J., Ciombor, K. K., Cohen, S., Cooper, H. S., Deming, D., Engstrom, P. F., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0061 · Cited by 944
Burstein, H. J., Krilov, L., Aragon-Ching, J. B., Baxter, N. N., Chiorean, E. G., Chow, W. A., De Groot, J. F., Devine, S. M., DuBois, S. G., El-Deiry, W. S., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.5292 · Cited by 601
Metadata
- Authors
- Stevenson, A. R. L., Solomon, M. J., Lumley, J. W., Hewett, P., Clouston, A. D., Gebski, V. J., Davies, L., Wilson, K., Hague, W., & Simes, J.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2015-10-06
- Volume
- 314
- Issue
- 13
- Pages
- 1356
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1926888387
- Cited by
- 1,047
- References
- 14
- FWCI
- 38.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.